Not Applicable.
This application relates to a wound care device which can be used to compress and stabilize tissue about a wound into a desired position and shape to aid and facilitate the healing of the wound and to a new material from which the wound care device is made and which can also be used for negative wound pressure therapy drapes.
Mammalian, and in particular, human, skin comprises two layers. The epidermis and dermis. The epidermis is the outer layer of skin and forms a protective barrier; the dermis is below the epidermis and contains connective tissues which cushion the body from stress and strain. Below the dermis is subcutaneous tissue (or hypodermis) which connects the skin to underlying bone and muscle and supplies the skin (the dermis and epidermis) with blood and nerve cells. When a wound occurs in the dermis of human skin (such as by incision, biopsy, sores, etc.), the wound begins to heal by a complex process where the tissue surrounding the wound site ensues with the formation of a collagen foundation, upon which new connective tissue fibers, called fibroblasts, can begin to grow. As healing continues, the fibroblasts attach to the surrounding tissue, the edges of the open wound shrink to begin a wound closure phase. As the fibroblasts continue to form, they continue shrinking or reducing the margins (edges) of the wound thereby closing (and healing) the wound.
As healing continues, the fibroblasts that form on the collagen foundation eventually draw the wound to complete closure, at which point, the wound margins come into contact. The fibroblasts mature at this point, as the collagen transforms into permanent scar tissue in which the wound is closed and sealed.
Throughout the healing process, the open wound continues to be susceptible, and remains sensitive, to natural movement in the surrounding skin. Excessive natural movements may disrupt the connective tissue that is formed by fibroblasts during wound healing and closure. In some cases, the formation of fibroblasts may be completely prevented, thereby causing delays in the healing process. The breakdown of the connective tissue will delay the healing process. Furthermore, the open wound remains susceptible to infection, which can further delay, or complicate, the healing process.
During healing, as the margins of the wound shrink, the surrounding dermis begins to revert to its original position. Current wound covers cannot adapt to this retraction, and thus will need to be adjusted, or a new wound cover will need to be applied. Further, typically the adhesive used on current wound covers is composed of an acrylate adhesive, which is known to bond to skin, including new skin, as it is formed. When the wound cover needs to be removed and replaced, the adhesive may have bonded to the skin which can cause dermal stripping, impeding healing of the wound. Additionally, during removal of typical wound covers, the adhesive can simply cause irritation to both the healing tissue and the existing skin surrounding the wound. This causes pain and may delay the healing process. Further, multiple dressing changes enhance the likelihood of complications.
In negative wound pressure therapy, a negative wound pressure therapy drape is applied to the skin about the wound or wound dressing. The drape is connected to a vacuum source which can then draw a vacuum on the wound. This therapy aids healing by removing gasses and excess exudate from the wound. However, as with conventional wound covers, conventional wound pressure therapy drapes adhere to the skin, and when they are removed, they can cause dermal stripping. As can be appreciated, such dermal stripping can negatively impact healing, especially for wounds such as skin grafts and in burn victims.
In view of the above-noted shortcomings, it would be desirable to provide a new wound care device that can be used not only to cover a wound but to enhance the wound healing process and to provide a material from which the wound care device can be made. Such a wound care device has a memory, is flexible and is adequately sized to affect the dermis surrounding a wound as the wound heals. The wound care device is adhered to skin using an adherent material that is gentle to the skin during both long-term use and which allows for atraumatic removal of the device, or which does not irritate the skin surrounding the wound or otherwise interrupt the healing process. The objective is to provide a device intended for long-term wear that is easily applied, which facilitates uninterrupted wound healing (UWH) and greatly reduces the need for dressing changes.
Briefly stated, a wound care device is disclosed that can be used to aid in the wound healing process. Once applied to the wound, the wound care device provides support to the dermis and epidermis to preserve fibroblast structures. By reducing the potential for movement of the tissue surrounding the wound and wound margins, the wound care device will protect and stabilize the wound and the periwound, thus allowing healing to commence.
In accordance with another aspect, a tissue stabilizing wound care device is provided that adds compression to a wound while minimizing movement of the wound and wound margins to improve healing. This tissue stabilizing wound care device can be adapted to be applied directly over the wound, or it can be applied over a dressing which covers the wound.
In another mode, the wound care device can be used as a negative wound pressure therapy (NWPT) cover. A port or valve may be placed within the body area of the wound care device, which permits attachment of tubing. The device will cover a NWPT dressing while allowing a complete seal to produce a more secure vacuum. This stabilizes the area around the wound, thereby enhancing wound healing and preventing excessive scarring.
Briefly stated, wound care device is provided to aid in the healing of a wound by providing stability to tissue of both the wound and periwound while reducing and absorbing sheer forces directed to the wound that would otherwise disrupt connective tissue of the wound. The wound care device comprises a cover layer having a bottom surface. The cover layer is made from a flexible ply that is stretchable in at least one direction along an axis and which has an elastic memory such that upon stretching the first layer will tend to retract to an at-rest position. A layer of adherent which is selected to adhere to a person's skin and to be removable form the skin atraumatically is applied to the bottom surface of the cover layer. Lastly, a removable release liner is positioned adjacent the layer of adherent to protect the adherent prior to application of the cover layer to a patient.
In use, the wound care device is applied to a person's skin over or adjacent the wound or wound dressing in a stretched/elongated condition with a first portion of the device adhered to the periwound at a first site proximate the wound and a second portion of the device is adhered to the periwound at a second site proximate to the wound, the second site being a side of the wound opposite of the first site, wherein, upon application of the wound care device, the energy stored in the wound care device from stretching the wound care device causes the first layer to retract along lines of tension towards a center or focal point of the lines of tension, thereby drawing the margins of the wound together to stabilize and compress the skin about the wound.
The wound care device can have the following characteristics, which can be combined in any desired manner:
In accordance with one aspect of the wound care device, the adherent is adapted to transfer tensions in tissue surrounding the wound caused by natural movement of the skin proximate the wound to the cover layer, thereby diverting sheer forces to the cover layer that would interrupt the healing process or that otherwise would be transferred directly to the wound promoting uninterrupted wound healing. The gel adhesive works in conjunction with the cover ply to elongate and accumulate sheer forces to absorb destructive forces which might otherwise be transferred to the wound. In doing so, the wound care device limits the tangential force applied to the skin.
In accordance with an aspect of the wound care device, the adherent has an adhesive strength such that when sheer forces accumulated in the adherent exceed engineered design limitations of the adherent (such as the adhesive strength of the adherent), the wound care device will release from the skin before injury can occur to the skin, limiting the tangential forces applied to the skin of the patient.
In accordance with another aspect, a sheet material is provided which is useable for wound care devices or negative pressure wound therapy. The sheet material comprises a cover or top layer formed from a woven or knit fabric comprised of fibers such that the sheet material is stretchable and has an elastic memory. The cover layer comprises a plurality of fibers extending from a bottom surface thereof. A binder, such as an acrylate adhesive, is applied to the bottom surface of the cover layer, and the fibers extend into the binder, whereby the binder adheres to the fibers along lengths of the fibers. This increases the surface area of the cover layer to which the adhesive can adhere. Lastly, the material has a bottom layer comprised of a gel adhesive, such as silicone gel (preferably a heavy coat weight silicone gel) or a hydrogel. The adhesive is an adhesive which will bond to the gel adhesive to securely adhere the gel adhesive to the top layer.
In an aspect of the sheet material, the sheet material can be provided with a release liner removably adhered to the gel adhesive to protect the gel adhesive until the sheet material is ready to be used.
The sheet material can have the following characteristics, which can be combined in any desired manner:
A method for producing the sheet material is disclosed. The method comprises brushing or abrading a surface of the cover layer to cause the fibers to extend from said surface area available for bonding; applying the binder to the surface of the cover layer such that said fibers extend into the adhesive to enable the adhesive to bind to surfaces of the fibers; and applying the layer of gel adhesive over the binder whereby said layer of gel adhesive binds to said binder to be securely affixed to said cover layer.
In accordance with an aspect, a method of stabilizing and compressing dermis tissue proximate a wound is provided using either the wound care device or the sheet material as described above. The method comprises:
Application of the wound care device/sheet material to the patient places the tissue immediately under the wound care device/sheet material in compression, and places the tissue of the periwound surrounding the wound care device/sheet material is in tension. As such, the method relieves tension on the wound and the wound margins.
Further, the wound care device/sheet material transfers stresses in the tissue caused by natural movement of the skin proximate to the wound through the adherent layer to the cover layer, thereby diverting and absorbing sheer forces that would interrupt the healing process or otherwise be transferred directly to the wound.
In accordance with an aspect of the method the step of applying the wound care device to the patient comprises applying the cover layer over the wound, whereby the cover layer forms a protective barrier over the wound.
In accordance with an aspect of the method, application of the cover layer to the patient comprises an initial step removing a backing layer to expose the adherent/gel adhesive. In an aspect of the method, the release layer comprises a first portion and a second portion; and the steps of removing the release liner and adhering the stretched wound care device to the patient comprise: removing a first portion of a release layer of the device to expose a first portion of an adherent/gel adhesive and adhering the first portion of the adherent/gel adhesive to skin adjacent the wound; then removing a second portion of the release layer to expose a second portion of the gel adhesive, stretching/elongating the cover layer, and adhering the second portion of the gel adhesive to the skin on a side of the wound opposite the first portion of the device.
In a variation of the method, the cover layer is elongated prior to application to the patient and then attached, both sides at the same time, to the periwound.
Preferably the cover layer is larger than the wound in at least one dimension; wherein the retraction forces generated by the memory of the cover layer decrease with distance from the margin of the device.
Even more preferably, the cover layer is larger than the wound in all directions, is stretchable in multiple directions, such that the memory of the material of the cover layer retracts along multiple axes toward the center point. In this instance, the cover layer is deemed to be omnidirectional.
In accordance with an aspect of the method, the cover layer can be selectively stretched in desired directions to accommodate variations of the wound site and to selectively vary the forces exerted by the cover layer on selected areas of the wound, whereby, the forces can be greater in one area of the wound than in another area of the wound.
Similarly, the method can include a step of selectively shaping the cover layer, such as by cutting, to shape the cover layer so that it will be uniquely loaded to accommodate the needs of the wound and to selectively control the forces applied by the wound care device to various portions of the wound.
In accordance with an aspect of the method, once adhered to the skin of a person, the memory of the cover layer remains under a continuous tension for the duration that it is worn. Preferably, the wound care device remains in place on the epidermis as a cover of a wound for extended periods of time, and preferably until the wound heals.
In accordance with an aspect of the method, the wound care device can be adapted for use in as negative wound pressure therapy. This involves (1) connecting the cover layer to a vacuum source to place the wound under negative pressure, or (2) applying a negative wound pressure therapy drape over the wound care device, with the wound care device being applied to the patient. In this alternative, the cover layer is between the patient and the negative would pressure therapy drape, such that the negative wound pressure therapy drape does not contact the patient's skin.
When used for negative wound pressure therapy, it is preferably that the wound care device has adherent free areas. The step of applying the wound care device to the patient thus comprises positioning the wound care device such that the adherent free area is over the wound or wound dressing. Preferably, the window defines an area generally equal to, or greater than, an area of the wound.
In accordance with an aspect of the method, application of the cover layer substantially seals the wound from the ambient atmosphere, thereby reducing the need for dressing changes and promoting uninterrupted wound healing.
In accordance with a different aspect, a method of conducting negative pressure is disclosed, this method comprising: applying a wound cover over a wound to be treated; the wound cover comprising a wound care device or a sheet material as described above, and subjecting the wound to a vacuum pressure. In one aspect, the wound cover is directly connected to a source of vacuum. In another aspect, the method includes a step of applying a negative would pressure drape over the wound cover; and connecting the negative wound pressure drape to a source of vacuum.
Finally, also disclosed are uses of the wound cover device and the sheet material as (1) a scar therapy or scar-reduction device and (2) as a negative wound pressure therapy drape.
Corresponding reference numerals will be used throughout the several figures of the drawings.
The following detailed description illustrates the claimed invention by way of example and not by way of limitation. This description will clearly enable one skilled in the art to make and use the claimed invention, and describes several embodiments, adaptations, variations, alternatives and uses of the claimed invention, including what we presently believe is the best mode of carrying out the claimed invention. Additionally, it is to be understood that the claimed invention is not limited in its application to the details of construction and the arrangements of components set forth in the following description or illustrated in the drawings. The claimed invention is capable of other embodiments and of being practiced or being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting.
In the case of an open wound, a wound care device 10 can be placed over or adjacent the wound to aid in the healing process. Whether the wound care device is placed over or adjacent the wound depends on the type of wound and the needs of the particular patient. As is known, some wounds (such as, for example, incisions) are closed, and some wounds are allowed to heal as an open wound (in which dressings are changed). The wound care device 10 can be used with either type of wound. For wounds that are closed, the wound care device supports or can be used with any type of closure method (i.e., sutures, stapes, skin glue, Steri-Strip® closures, etc.).
A wound care device 10 is illustratively shown in
With reference to
The cover layer 16 is composed of a, preferably polymer or polymer containing, material that is capable of flexing and stretching. The material is preferably a polymer (such as nylon) or a polymer containing material (i.e., a blend of natural and man-made fibers). This material can be knit fabric, a woven fabric, or fleece. The material can have an elongation factor of at least 50% and up to 500%. For example, the material can have an elongation factor of 150%. In one variation, the material is stretchable along just one direction or axis; and in another variation, the material is stretchable in many directions or axes (i.e., it stretches omni-directionally). Preferably, the material of the top ply is generally fluid impermeable, but has a moisture vapor transmission rate (MVTR). For example, the top ply can have an MVTR of approximately 100-400 gm/m2/24 hours or greater. As will be described more fully below, despite the liquid impermeability, liquid can be drawn through the cover layer 16 under vacuum pressure. For example, the material of the cover layer is fluid permeable when subjected to a vacuum such as between −200 and −40 mmHg or greater. The material from which the top layer is made can also be hydrophobic. The material from which the top layer 16 is made preferably has an elastic memory such that it has an original at-rest shape and size and upon stretching, the material will tend to revert back to the at-rest shape and size. The elasticity of the top layer is dynamic, such that the forces applied by the top layer due to its elastic memory are linear. The cover layer 16 can, for example be made from a woven nylon, such as is described in U.S. Pat. No. 9,439,808, which is incorporated herein by reference. Alternatively, the fabric layer can be made from a warp knit fabric, such as a tricot knit fabric, preferably of nylon.
The adherent 19 may be comprised of a silicone gel material, a hydrogel adhesive, or a co-adhesive. As is known, silicone gels and hydrogels do not bond to the skin and are gentle on the skin during removal. They are typically composed of a very lightly cross-linked silicone elastomer whose polymer network has been swollen with silicone fluids. In a variant, the adherent can have an integrated medicant.
In an alternative, as seen in
An optional binder agent 17, such as an acrylate adhesive, can be used to adhere the adherent 19 to the cover layer 16. The adherent 19 extends substantially over the entire lower surface of the cover layer 16. If an acrylate adhesive binder is used, the silicone gel or hydrogel will cover the acrylate adhesive, such that the acrylate adhesive will not come into contact with the patient's skin. As seen, the release liner 22 does not directly contact the cover layer 16. Thus, the release liner 22 is removably adhered to the bottom of the cover layer by the adherent 19.
The release layer 22 is preferably made from a generally non-stretchable material. The release liner 22, as shown in
For purposes of manufacturing the device 10, the cover layer 16 and the adherent 19 can be provided as a sheet assembly which is then combined with the release layer 22. The cover layer 16 with the adherent 19 is more pliable and more stretchable than the release layer 22. In production, a single multi-ply sheet is formed by positioning the cover layer 16 with the adherent 19 on the release liner 22 to removably adhere the release liner 22 to the adherent 19. The application of the release liner 22 to the combined cover layer and adherent can be accomplish by any desired technology. The device 10 can then be die cut from the sheet so formed.
We have found that release liner adheres to the silicone gel 19 better than the silicone gel adheres to the top layer. Thus, when the release liner was removed, it could pull the silicone gel with it. The use of the binder 17 improved this situation. The binder can be, for example, an acrylate adhesive which will bond to the silicone gel. However, we have found that using an assembly, such as shown schematically in
In use, the wound care device is applied in a stretched/elongated condition or state to cover the wound or a wound dressing (as shown in
This application of the device is shown illustratively in
In
The application of the wound care device is also shown cross-sectionally in
The effect of the forces on the wound 30 can be seen by comparing position of the wound margin reference line MRL and the skin tension line with respect to the wound 30. As can especially be seen by comparing
The images of
With reference to
These lines of force are further shown in
Initially, it is believed that by compressing and stabilizing the wound and the periwound, the fibroblasts and connective tissues formed during wound healing can form generally unimpeded. Further, it is believed that the forces, such as tension and sheer forces, that would normally be transferred to the wound are instead transferred to, and absorbed in, the wound care device, such that these forces are directed away from the wound. This further allows for the unimpeded growth of fibroblasts and connective tissue, which leads to healing of the wound.
As noted above, the wound care device is highly stretchable, and can be elongated in at least one axis, and preferably along multiple axes. When the device is stretched along just one axis, it is adapted for use with acute wounds, such as incisions resulting from surgery. However, when the device is omni-directional, and can stretch along multiple axes, the wound care device can be used with irregularly shaped wounds, such as might occur from fistulas, abscesses, biopsies, etc. Because the omni-directional wound care device is stretchable along multiple axes, it can be uniquely loaded to accommodate the requirements of the wound site. That is, by selectively shaping the wound care device, it can be made to vary the stresses placed on the wound and the periwound, and the forces can be limited in some areas and increased in others.
The wound care device can be applied directly over the wound or wound dressing (as shown in
Once the wound is healed or sealed, the wound care device 10, 10′ can be repurposed for use as a scar therapy or scar-reduction device to minimize the effects of scarring at the wound site. Scar therapy requires that the device be placed directly over the wound site (i.e., applied directly to the skin around the wound), or over an existing wound dressing. This scar therapy function of the device reduces and minimizes hypertrophic, keloid and other scars resulting in a better cosmetic effect. If desired, prior to repositioning the wound care device, the wound care device can be removed from the patient, sterilized, cleaned, and then reapplied to the wound or incision for scar therapy. As noted above, the preferred embodiment of the wound care device (shown in
Additionally, the wound care device can be used for negative wound pressure treatment (NWPT), in a similar manner as discussed in our U.S. Pat. No. 10,849,704, which is incorporated herein by reference. For negative wound pressure treatment, a vacuum port 43 is formed in the wound care device. The wound care device can then be provided with a connector or tube 32, as seen in
In some instances, it may not be desirable to remove and reapply a wound care cover/negative pressure wound therapy drape. In this instance, a (traditional) negative wound pressure therapy drape 54, as shown in
In certain situations, it may not be desirable to place the wound tissue in compression when using negative pressure wound treatment. In this instances, the wound care device 10, 10′ can be applied to cover the wound in a relaxed or static state (i.e., the cover layer 16 will not be stretched during application of the device). Although the cover layer will be applied in a relaxed or static condition, the gel adhesive (the silicone gel) will still form a seal about the wound so that a vacuum can be applied to the wound.
Additionally, the wound care device can be adapted and configured to monitor the healing of the wound. To monitor the wound, the device 10 is provided with monitoring means 40 (
We have found that the materials from which the device 10 is made has surprising results during use. A prototype device was worn by a patient having a large fistula that had remained unhealed for fourteen (14) months prior to application of the prototype device. The prototype device was applied over the wound. Rows 1-5 of
The prototype device used, as is device 10, was comprised of a woven nylon fabric layer with a LDPE release layer releasably adhered to a bottom surface of the nylon fabric layer by means of an adherent (such as a gel silicone and a binder and/or an acrylate adhesive).
As various changes could be made in the above constructions without departing from the scope of the invention, it is intended that all matter contained in the above description or shown in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense.
This application claims priority to U.S. application Ser. No. 62/981377 filed 25 Feb. 2020 and entitled “Convertible Tissue Retractor/Wound Cover.” The contents of said application (including drawings and claims) are incorporated herein by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/019615 | 2/25/2021 | WO |
Number | Date | Country | |
---|---|---|---|
62981377 | Feb 2020 | US |